Dymon Asia Capital (Singapore)’s Teladoc Health TDOC Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,000	Closed	-$1.08M	–	163
2022 Q1	$1.08M	Sell	15,000 -30,000	-67%	-$2.16M	0.08%	83
2021 Q4	$4.13M	Sell	45,000 -65,000	-59%	-$7.77M	0.42%	38
2021 Q3	$13.9M	Hold	110,000	–	–	1.54%	7
2021 Q2	$18.3M	Buy	110,000 +80,000	+267%	+$13M	1.92%	4
2021 Q1	$5.45M	Buy	+30,000	New	+$6.96M	0.38%	29

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s TDOC Position: Q2 2022 in Review

Dymon Asia Capital (Singapore) sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 14,370 shares — an estimated $1.04M sold.

Dymon Asia Capital (Singapore) first reported a position in TDOC in Q1 2021 and held it in 5 quarters. The position peaked at $10.4M in Q3 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Dymon Asia Capital (Singapore) reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Dymon Asia Capital (Singapore) sold 14,370 Teladoc Health shares in Q2 2022, an estimated $1.04M.
Dymon Asia Capital (Singapore) first reported a position in Teladoc Health in Q1 2021 and held it in 5 quarters.
Dymon Asia Capital (Singapore)'s Teladoc Health position peaked at $10.4M in Q3 2021.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2022, filed 12 Aug 2022.